Clinical Trial Update: A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-39439335 in Patients With Osteoarthritis [Phase 1]

View source ↗

Summary

The clinical trial update confirms the completion of a Phase 1 multiple-dose study of JNJ-39439335 in knee osteoarthritis, evaluating safety, tolerability, phar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• JNJ-39439335

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Osteoarthritis, Knee | Phase 1 | Status: COMPLETED